Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
17.04. | GSK kicks off Blenrep's market return with first myeloma combo nod in UK | ||
17.04. | TV drug ad spending continues upward climb, logging nearly 30% growth in Q1 | ||
17.04. | AstraZeneca's Alexion accused of extending Soliris monopoly through sham patents in new suit | ||
17.04. | RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance | ||
17.04. | Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant | ||
17.04. | Ipsen's liver disease drug Iqirvo off to promising launch in battle with Gilead's Livdelzi | ||
16.04. | RFK Jr. targets HHS' vaccine safety reporting system, pledges changes: Stat | ||
16.04. | CDC vaccine panel review indicates potential changes to COVID, HPV immunization policies | ||
16.04. | GSK scolded after complainant flags 'shocking error' in prescribing information | ||
16.04. | Trump throws pharma 'bread crumb' concession with call to end IRA pill penalty | ||
16.04. | With looming Trump tariffs, pharma companies demand changes to stay in EU | ||
16.04. | Bluebird, after exploring 2nd buyout offer, sticks with Carlyle and SK Capital deal | ||
15.04. | Apellis, AstraZeneca break down their FierceMadness 2025 Drug Ad Tournament success | ||
15.04. | As Johnson & Johnson navigates changing tariff landscape, execs lay out their expectations | ||
15.04. | BMS' growth driver Camzyos fails in heart disease trial, denting expansion opportunity | ||
15.04. | After delay, first CDC vaccine panel under RFK Jr. meets to hash out recommendations | ||
15.04. | Sanofi signs up Chrissy Teigen for diabetes screening campaign | ||
15.04. | Trump administration launches national security investigation into pharmaceuticals, paving way for tariffs | ||
14.04. | Amgen bumps up pay for longtime CEO Robert Bradway 8% to $24.4M | ||
14.04. | Aurobindo gets Form 483 scolding from FDA at North Carolina inhaler plant | ||
14.04. | RFK Jr. blasts FDA as industry's 'sock puppet,' warns about 'deep state' influence at agency: Politico | ||
14.04. | Sandoz takes Amgen to court again, challenging its patents on decades-old Enbrel | ||
14.04. | In short reprieve for pharma, commerce secretary says drug tariffs to come 'in the next month or two' | ||
14.04. | 'Saturday Night Live' skewers drug ad tropes in Jon Hamm-led skit | ||
14.04. | Gilead reprimanded after PMCPA finds conference Wi-Fi sponsorship broke advertising rules |